FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200179903> ?p ?o ?g. }

• W4200179903 abstract "Evidence is emerging for the use of overground lower limb robotic exoskeletons in the rehabilitation of people with spinal cord injury (SCI), with suggested benefits for gait speed, bladder and bowel function, pain management and spasticity. To date, research has focused on devices that require the user to support themselves with a walking aid. This often precludes use by those with severe trunk, postural or upper limb deficits and places the user in a suboptimal, flexed standing position. Free-standing exoskeletons enable people with higher level injuries to exercise in an upright position. This study aimed to evaluate the feasibility of therapy with a free-standing exoskeleton for those with SCI, and to determine the potential health-related benefits of this intervention.This 12-week intervention study with 12-week waitlist control and 12-week follow up, provided people with SCI scoring < 5 on the mobility section of the spinal cord independence measure (SCIM-III) twice weekly therapy in the REX (Rex Bionics, Auckland, NZ), a free-standing lower limb robotic exoskeleton. The primary outcome measure of interest was function, as measured on the SCIM-III. A battery of secondary outcomes was included. Participants also completed a survey on their perceptions of this treatment modality, to determine acceptability.Forty-one potential participants were screened for eligibility. Two females (one ASIA A, one ASIA C) and one male (ASIA B) completed all 24 intervention sessions, and the follow up assessment. One participant showed positive trends in function, fatigue, quality of life and mood during the intervention phase. Grip and quadriceps strength, and lower limb motor function improved in another. Two improved their percentage of lean body mass during the intervention phase. Remaining results were varied across patients, time points and outcomes. The intervention was highly acceptable to all participants.With three of 41 potential participants being eligible and completing this study, our results show that there are potential benefits of exercise in a free-standing exoskeleton for people with severe mobility impairment due to SCI, for a small subset of patients. Further research is warranted to determine those most likely to benefit, and the type of benefit depending on the patient characteristics. Trial registration The trial was registered prospectively on 20 April 2018 at www.anzctr.org.au/ (ACTRN12618000626268)." @default.
• W4200179903 created "2021-12-31" @default.
• W4200179903 creator A5001874781 @default.
• W4200179903 creator A5003437570 @default.
• W4200179903 creator A5038691807 @default.
• W4200179903 creator A5065845532 @default.
• W4200179903 date "2021-12-01" @default.
• W4200179903 modified "2023-10-16" @default.
• W4200179903 title "Physiotherapy using a free-standing robotic exoskeleton for patients with spinal cord injury: a feasibility study" @default.
• W4200179903 cites W1579950305 @default.
• W4200179903 cites W187583962 @default.
• W4200179903 cites W1987138256 @default.
• W4200179903 cites W1994150380 @default.
• W4200179903 cites W2022410055 @default.
• W4200179903 cites W2025548235 @default.
• W4200179903 cites W2026523445 @default.
• W4200179903 cites W2027100275 @default.
• W4200179903 cites W2027582423 @default.
• W4200179903 cites W2036831136 @default.
• W4200179903 cites W2067865542 @default.
• W4200179903 cites W2070825536 @default.
• W4200179903 cites W2074207427 @default.
• W4200179903 cites W2087759294 @default.
• W4200179903 cites W2094506848 @default.
• W4200179903 cites W2127536823 @default.
• W4200179903 cites W2128876492 @default.
• W4200179903 cites W2161001082 @default.
• W4200179903 cites W2165322933 @default.
• W4200179903 cites W2165758561 @default.
• W4200179903 cites W2250235904 @default.
• W4200179903 cites W2295429002 @default.
• W4200179903 cites W2299822594 @default.
• W4200179903 cites W2304549287 @default.
• W4200179903 cites W2482338216 @default.
• W4200179903 cites W2564577061 @default.
• W4200179903 cites W2634014678 @default.
• W4200179903 cites W2768059182 @default.
• W4200179903 cites W2770897917 @default.
• W4200179903 cites W2780889524 @default.
• W4200179903 cites W2796370752 @default.
• W4200179903 cites W2799981557 @default.
• W4200179903 cites W2886615227 @default.
• W4200179903 cites W2889562875 @default.
• W4200179903 cites W2891838095 @default.
• W4200179903 cites W2891999396 @default.
• W4200179903 cites W2964298607 @default.
• W4200179903 cites W2976206830 @default.
• W4200179903 cites W2976690030 @default.
• W4200179903 cites W2995220928 @default.
• W4200179903 cites W2996578723 @default.
• W4200179903 cites W3004488687 @default.
• W4200179903 cites W3020887054 @default.
• W4200179903 cites W3104384563 @default.
• W4200179903 cites W3106958003 @default.
• W4200179903 cites W4235503616 @default.
• W4200179903 doi "https://doi.org/10.1186/s12984-021-00967-4" @default.
• W4200179903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34953501" @default.
• W4200179903 hasPublicationYear "2021" @default.
• W4200179903 type Work @default.
• W4200179903 citedByCount "4" @default.
• W4200179903 countsByYear W42001799032022 @default.
• W4200179903 countsByYear W42001799032023 @default.
• W4200179903 crossrefType "journal-article" @default.
• W4200179903 hasAuthorship W4200179903A5001874781 @default.
• W4200179903 hasAuthorship W4200179903A5003437570 @default.
• W4200179903 hasAuthorship W4200179903A5038691807 @default.
• W4200179903 hasAuthorship W4200179903A5065845532 @default.
• W4200179903 hasBestOaLocation W42001799031 @default.
• W4200179903 hasConcept C118552586 @default.
• W4200179903 hasConcept C146549078 @default.
• W4200179903 hasConcept C159110408 @default.
• W4200179903 hasConcept C1862650 @default.
• W4200179903 hasConcept C2778334475 @default.
• W4200179903 hasConcept C2778818304 @default.
• W4200179903 hasConcept C2779951463 @default.
• W4200179903 hasConcept C2780665704 @default.
• W4200179903 hasConcept C2780775167 @default.
• W4200179903 hasConcept C45391945 @default.
• W4200179903 hasConcept C71924100 @default.
• W4200179903 hasConcept C99508421 @default.
• W4200179903 hasConceptScore W4200179903C118552586 @default.
• W4200179903 hasConceptScore W4200179903C146549078 @default.
• W4200179903 hasConceptScore W4200179903C159110408 @default.
• W4200179903 hasConceptScore W4200179903C1862650 @default.
• W4200179903 hasConceptScore W4200179903C2778334475 @default.
• W4200179903 hasConceptScore W4200179903C2778818304 @default.
• W4200179903 hasConceptScore W4200179903C2779951463 @default.
• W4200179903 hasConceptScore W4200179903C2780665704 @default.
• W4200179903 hasConceptScore W4200179903C2780775167 @default.
• W4200179903 hasConceptScore W4200179903C45391945 @default.
• W4200179903 hasConceptScore W4200179903C71924100 @default.
• W4200179903 hasConceptScore W4200179903C99508421 @default.
• W4200179903 hasIssue "1" @default.
• W4200179903 hasLocation W42001799031 @default.
• W4200179903 hasLocation W42001799032 @default.
• W4200179903 hasLocation W42001799033 @default.
• W4200179903 hasLocation W42001799034 @default.
• W4200179903 hasOpenAccess W4200179903 @default.
• W4200179903 hasPrimaryLocation W42001799031 @default.
• W4200179903 hasRelatedWork W2304549287 @default.

• next